Top news
FDA, CDC lift pause on J&J Covid vaccinations
By Erika Edwards & Sara G. Miller
Congressional investigation launched into Emergent BioSolutions' federal vaccine contracts
By Rich Mendez
Federal Inspectors Fear More Vaccines Were Exposed to Contamination (Published 2021)
By Sharon LaFraniere, Chris Hamby & Sheryl Gay Stolberg
All coverage
Vaccinations are plateauing. Don't blame it on 'resistance'
By Stefanie Friedhoff
FDA report finds multiple failings at plant that ruined 15 million Johnson & Johnson vaccine doses
By Christopher Rowland
White House writes off Johnson & Johnson vaccine after string of production failures
By Sarah Owermohle, Adam Cancryn & Erin Banco
L.A. County prepping to resume administering Johnson & Johnson vaccine
By Luke Money & Colleen Shalby
Restart of the Johnson & Johnson COVID-19 vaccine: A doctor explains why benefits far outweigh risks
By William A. Petri
Johnson & Johnson COVID vaccine: Pause lifted by FDA, use to resume
By Karen Weintraub & Elizabeth Weise
CDC panel voted to resume J&J COVID-19 shots paused for clot concerns
By Tina Hesman Saey
Johnson & Johnson Vaccine: U.S. Lifts Pause : Coronavirus Updates
By Laurel Wamsley
U.S. ends J&J COVID-19 vaccine pause; shots to resume immediately
By Julie Steenhuysen & Manas Mishra
FDA finds poor conditions at Baltimore plant that ruined millions of doses of J&J Covid vaccine
By Berkeley Lovelace, Berkeley Lovelace Jr. & Amanda Macias
U.S. lifts pause on use of J&J's Covid-19 vaccine
By Helen Branswell
Emergent BioSolutions halts operations at its Baltimore plant, where J.&J. doses were ruined, at the F.D.A.'s request ...
By Sheryl Gay Stolberg
The F.D.A. ended its recommended pause on the J.&J. vaccine, clearing the way for states to use it again. (Published ...
By Carl Zimmer, Emily Anthes & Noah Mercer Weiland
The public's concerns over the Johnson & Johnson coronavirus vaccine are widespread, Post-ABC poll finds
By Scott Clement & Amy Goldstein